Literature DB >> 24365356

Porphyria and its neurologic manifestations.

Jennifer A Tracy1, P James B Dyck2.   

Abstract

Porphyrias are rare disorders resulting from a defect in the heme biosynthetic pathway. They can produce significant disease of both the peripheral and central nervous systems, in addition to other organ systems, with acute intermittent porphyria, hereditary coproporphyria, and variegate porphyria as the subtypes associated with neurologic manifestations. The presence of a motor-predominant peripheral neuropathy (axonal predominant), accompanied by gastrointestinal distress and neuropsychiatric manifestations, should be a strong clue to the diagnosis of porphyria. Clinical confirmation can be made through evaluation of urine porphyrins during an exacerbation of disease. While hematin is helpful for acute treatment, long-term effective management requires avoidance of overstimulation of the cytochrome P450 pathway, as well as other risk factor control.
© 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Porphyria; acute intermittent porphyria; autonomic neuropathy; encephalopathy; hematin; hereditary coproporphyria; peripheral neuropathy; variegate porphyria

Mesh:

Year:  2014        PMID: 24365356     DOI: 10.1016/B978-0-7020-4087-0.00056-5

Source DB:  PubMed          Journal:  Handb Clin Neurol        ISSN: 0072-9752


  13 in total

1.  Experiences and concerns of patients with recurrent attacks of acute hepatic porphyria: A qualitative study.

Authors:  Hetanshi Naik; Mikayla Stoecker; Saskia C Sanderson; Manisha Balwani; Robert J Desnick
Journal:  Mol Genet Metab       Date:  2016-08-24       Impact factor: 4.797

2.  Systemic inflammation in acute intermittent porphyria: a case-control study.

Authors:  E Storjord; J A Dahl; A Landsem; H Fure; J K Ludviksen; S Goldbeck-Wood; B O Karlsen; K S Berg; T E Mollnes; E W Nielsen; O-L Brekke
Journal:  Clin Exp Immunol       Date:  2016-12-15       Impact factor: 4.330

3.  A Neurologist's Practical Approach to Cognitive Impairment.

Authors:  Philip W Tipton; Gregory S Day; Neill Graff-Radford
Journal:  Semin Neurol       Date:  2021-11-26       Impact factor: 3.420

4.  Clinical Challenges of Acute Porphyria in the Young Adult.

Authors:  Shannon Burns; Allison Harmel; Sally Miller; Gabriela Figueiredo Pucci; Jonathan Greco; Michael Pulley; Michael Pizzi
Journal:  Neurohospitalist       Date:  2022-02-09

5.  Acute porphyria in a patient with Arnold Chiari malformation.

Authors:  Jianbin Shen; Kevin O'Keefe; Lisa B Webb; Angela DeGirolamo
Journal:  Am J Case Rep       Date:  2015-02-20

6.  A rare case of acute intermittent porphyria with ichthyosis vulgaris in a young boy.

Authors:  Garima Agrawal Varshney; Purti Agrawal Saini; Upendra Ghure
Journal:  J Family Med Prim Care       Date:  2018 Jan-Feb

Review 7.  Mitochondrial Targeting in Neurodegeneration: A Heme Perspective.

Authors:  Veronica Fiorito; Deborah Chiabrando; Emanuela Tolosano
Journal:  Pharmaceuticals (Basel)       Date:  2018-09-18

8.  Systematically Analyzing the Pathogenic Variations for Acute Intermittent Porphyria.

Authors:  Yibao Fu; Jinmeng Jia; Lishu Yue; Ruiying Yang; Yongli Guo; Xin Ni; Tieliu Shi
Journal:  Front Pharmacol       Date:  2019-09-13       Impact factor: 5.810

9.  A Unique Neuropsychiatric Syndrome in Variant Hereditary Coproporphyria: Case Report and Review of the Literature.

Authors:  Alex Baumgartner; Peter J Quesenberry
Journal:  J Hematol (Brossard)       Date:  2017-03-21

Review 10.  Unraveling the Role of Heme in Neurodegeneration.

Authors:  Deborah Chiabrando; Veronica Fiorito; Sara Petrillo; Emanuela Tolosano
Journal:  Front Neurosci       Date:  2018-10-09       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.